These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8029807)

  • 1. Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activity.
    Beving H; Eksborg S; Malmgren RS; Nordlander R; Rydén L; Olsson P
    Thromb Res; 1994 Apr; 74(1):39-51. PubMed ID: 8029807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
    Rizk M; Abdel-Rahman MS
    Prostaglandins Leukot Essent Fatty Acids; 1994 Nov; 51(5):363-7. PubMed ID: 7846108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on cyclo-oxygenase of low and high dose aspirin.
    Beving H; Eksborg S; Nordlander R; Olsson P; Olsson U
    Thromb Res; 1990 Jul; 59(2):227-35. PubMed ID: 2122535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
    Ali M; McDonald JW
    Prostaglandins Med; 1979 Dec; 3(6):327-32. PubMed ID: 121613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
    Preston FE; Greaves M; Jackson CA; Stoddard CJ
    Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
    Rao GH; Radh E; Johnson GJ; White JG
    Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
    Halushka MK; Walker LP; Halushka PV
    Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet cyclooxygenase expression in normal dogs.
    Thomason J; Lunsford K; Mullins K; Stokes J; Pinchuk L; Wills R; McLaughlin R; Langston C; Pruett S; Mackin A
    J Vet Intern Med; 2011; 25(5):1106-12. PubMed ID: 21985141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miconazole inhibition of platelet aggregation by inhibiting cyclooxygenase.
    Ishikawa S; Manabe S; Wada O
    Biochem Pharmacol; 1986 Jun; 35(11):1787-92. PubMed ID: 3087363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.